Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 3:7:611317.
doi: 10.3389/fmed.2020.611317. eCollection 2020.

Secondary Membranous Nephropathy. A Narrative Review

Affiliations

Secondary Membranous Nephropathy. A Narrative Review

Gabriella Moroni et al. Front Med (Lausanne). .

Abstract

Membranous nephropathy (MN) is a common cause of proteinuria and nephrotic syndrome all over the world. It can be subdivided into primary and secondary forms. Primary form is an autoimmune disease clinically characterized by nephrotic syndrome and slow progression. It accounts for ~70% cases of MN. In the remaining cases MN may be secondary to well-defined causes, including infections, drugs, cancer, or autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), urticarial vasculitis, sarcoidosis, thyroiditis, Sjogren syndrome, systemic sclerosis, or ankylosing spondylitis. The clinical presentation is similar in primary and secondary MN. However, the outcome may be different, being often related to that of the original disease in secondary MN. Also, the treatment may be different, being targeted to the etiologic cause in secondary MN. Thus, the differential diagnosis between primary and secondary MN is critical and should be based not only on history and clinical features of the patient but also on immunofluorescence and electron microscopy analysis of renal biopsy as well as on the research of circulating antibodies. The identification of the pathologic events underlying a secondary MN is of paramount importance, since the eradication of the etiologic factors may be followed by remission or definitive cure of MN. In this review we report the main diseases and drugs responsible of secondary MN, the outcome and the pathogenesis of renal disease in different settings and the possible treatments.

Keywords: HBV infections; NSAIDs; cancer; membranous lupus nephropathy; primary membranous nephropathy; secondary membranous nephropathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Primary membranous nephropathy. A light microscopy there is diffuse thickening of glomerular capillary walls due to the presence of many immunedeposits in subepithelial position.
Figure 2
Figure 2
Membranous nephropathy in a patient with lung cancer. At light microscopy together with the diffuse thickening of glomerular capillary walls, some infiltration of leukocytes is present in capillary lumens.
Figure 3
Figure 3
Lupus membranous nephropathy. At electron microscopy, sub-endothelial immune complexes deposits, structured in aggregates of concentric lamellae to form “finger prints” images; a tubulo-reticular inclusion (TRI) is observed in the endothelial cell. Bars: 500 nm.

References

    1. Beck LH, Jr, Bonegio RG, Lambeau G, Beck DM, Powel DW, Cummins TD, et al. . M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. (2009) 361:11–20. 10.1056/NEJMoa0810457 - DOI - PMC - PubMed
    1. Tomas NM, Beck LH, Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, et al. . Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. (2014) 371:2277–87. 10.1056/NEJMoa1409354 - DOI - PMC - PubMed
    1. Salant DJ. Unmet challenges in membranous nephropathy. Curr Opin Nephrol Hypertens. (2019) 28:70–6. 10.1097/MNH.0000000000000459 - DOI - PMC - PubMed
    1. Elewa U, Sandr AM, Kim WR, Fervenza FC. Treatment of hepatitis b virus-associated nephropathy. Nephron Clin Pract. (2011) 119:c41–9. 10.1159/000324652 - DOI - PubMed
    1. Lai KN, Ho RTH, Tam JS, Lai FMM. Detection of hepatitis B virus DNA and RNA in kidneys of HBV-related glomerulonephritis. Kidney Int. (1996) 50:1965–77. 10.1038/ki.1996.519 - DOI - PubMed

Publication types